Clinical MR imaging in Parkinson’s disease: How useful is the swallow tail sign?
Open Access
- 24 May 2021
- journal article
- research article
- Published by Wiley in Brain and Behavior
- Vol. 11 (7) , e02202
Abstract
Background: With conventional MRI, no Parkinson's disease (PD)‐specific abnormalities can be detected. However, there is a critical need for accompanying neuroimaging markers to guide the diagnosis. With high‐resolution susceptibility‐weighted MRI (SWI) sequences, the imaging of nigrosome‐1 (N1) is possible. The so‐called swallow tail sign (STS) has been proposed as a suitable neuroimaging marker for the diagnosis of PD.Objectives: To investigate whether the absence of the STS can be applied for distinguishing PD patients from healthy controls (HCs).Methods: SWI images of 44 PD patients and 50 age‐ and gender‐matched HCs were investigated using a 3T MRI scanner. Two trained neuroradiologists blind‐rated the images and evaluated whether the STS was absent (1) on one side or (2) both sides of the participant's midbrain.Results: Our results confirmed good interrater reliability comparable to previously published studies. However, we did not identify any group differences between PD patients and HCs. Measures of diagnostic values revealed overall poor diagnostic performance.Conclusions: Even though previously stated, our study does not confirm the potential use of the STS as a supportive neuroimaging marker for PD in a clinical setting. In conclusion, there is a critical need for improvements in N1‐targeted MRI sequences and the development of advanced segmentation algorithms.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (BR4328.2‐1, DFG‐GEPRIS 413535489, GRK1957)
This publication has 14 references indexed in Scilit:
- MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia?American Journal of Neuroradiology, 2017
- Can loss of the swallow tail sign help distinguish between Parkinson Disease and the Parkinson-Plus syndromes?Clinical Imaging, 2017
- Meta‐analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's diseaseMovement Disorders, 2017
- Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson’s Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot StudyPolish Journal of Radiology, 2016
- Drug-induced Parkinsonism versus Idiopathic Parkinson Disease: Utility of Nigrosome 1 with 3-T ImagingRadiology, 2016
- Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I‐FP‐CIT SPECTMovement Disorders, 2016
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3TPLOS ONE, 2014
- Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: A meta-analysis of published studiesParkinsonism & Related Disorders, 2012
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977